Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts

Sunday, February 1, 2009

Are layoffs raising? Reports say 9,000 job vanishing each day

More and more people are becoming unemployed this year, with nearly 9,000 jobs vanishing worldwide on an average each day in January.

As the financial turmoil continues to rattle world economies, layoffs so far this year have crossed the 2,77,000 -mark with a stunning 80,000 job cuts announced January 26.

Right from electronics to telecom to pharma sectors, about 9,000 jobs were lost on an average every day this month.

Among the entities, construction machinery manufacturer Caterpillar, Japanese electronics major NEC and pharma giant Pfizer have announced over 20,000 job cuts each.

Dutch entities - electronics firm Philips and financial services company ING - together would be axing 13,000 jobs in the coming months.

Caterpillar, Pfizer, telecom firm Sprint Nextel Corp and home improvement retailer Home Depot together accounted for 61,000 lay-off announcements on January 26. The total job cuts announced on that day worldwide had crossed 80,000.

The bankruptcy of American electronics retailer Circuit City is expected to affect 30,000 employees whereas aluminium manufacturer Alcoa would be laying off 13,500 people.

Further, Indian conglomerate Tatas-owned UK steel maker Corus would be reducing its workforce by 3,500.

Other entities which unveiled plans to bring down headcount in January include TDK (8,000), BHP Billiton (6,000), Ericsson (5,000), Corning (4,900), Motorola (4,000), Texas Instruments (3,400), Honda (3,100), Kodak (3,000), Ford Motor (1,200) and Harley-Davidson (1,100).

Companies worldwide are bringing down their workforce as they explore ways to battle the dire economic situation. With consumer and business spending being crimped, many of the developed nations have already entered into recession.

Agencies

Will Glaxo SmithKline layoff 6,000 workers?

Glaxo SmithKline, Britain's biggest pharmaceuticals company, plans to axe around 6,000 jobs around the world as it faces up to the growing challenges in the industry, a media report said.

The cuts are expected to include hundreds of British jobs, The Sunday Telegraph claimed.

"Competition from generic manufacturers and doubts about company's (product) pipelines are posing a serious threat to the sector and, ING analysts warned of an intellectual property meltdown as top-selling products come off patent and sales slow dramatically", the newspaper stated.

The pharma major's British rival, Astra-Zeneca, told the newspaper that it would cut 15,000 staff by 2013, 6,000 more than earlier stated, while industry leader Pfizer has acquired US rival Wyeth for $68 bn as it seeks to secure its future.

Glaxo SmithKline, the world's second biggest drugs company behind Pfizer, employs about 1,00,000 people and, although yet to be confirmed, a proportion of the cuts are almost certain to be among its 18,000 staff at sites across the UK, which would strike another blow to the battered economy, the report said.

Agencies

Total Pageviews